Aspira Women's Health Inc. (AWHL) Insider Trading

Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Sep 2025.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

Sep 2025

Sep 17, 2025

Get an email when AWHL's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jun 5	Jack W Schuler Large holder	Bought	222,222	$0.45	$100k	5.8%	Form 4
Sep 17, 2025	John D Fraser Director	Bought	16,389	$0.45	$7k	2.0%	Form 4
Sep 17, 2025	Jeffrey K Cohen Director	Bought	55,556	$0.45	$25k	14%	Form 4
Sep 17, 2025	Jack W Schuler Large holder	Bought	1,111,111	$0.45	$500k	41%	Form 4

Jun 5
Jack W Schuler
Large holder · bought 222,222 at $0.45
$100k
5.8% of stake
Sep 17, 2025
John D Fraser
Director · bought 16,389 at $0.45
$7k
2.0% of stake
Sep 17, 2025
Jeffrey K Cohen
Director · bought 55,556 at $0.45
$25k
14% of stake
Sep 17, 2025
Jack W Schuler
Large holder · bought 1,111,111 at $0.45
$500k
41% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch AWHL, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: In Vitro & In Vivo Diagnostic Substances

CLDXCelldex Therapeutics Inc.

QCLSQ/C Technologies, Inc.

IMDXInsight Molecular Diagnostics Inc.

RGBPRegen Biopharma Inc.

ZIVOZivo Bioscience Inc.

LIXTLixte Biotechnology Holdings Inc.

WINTWindtree Therapeutics Inc.

CLNNClene Inc.

Spot a number that looks wrong? Check it in AWHL's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing AWHL

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.